Antalya Egitim ve Arastirma Hastanesi

Antalya 07100

0 studies enrolling now · 3 studies all time

What they study most

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Multiple Myeloma, Ulcerative Colitis

Studies at this site

• A Study Comparing Talquetamab in Combination With Daratumumab or in Combination With Daratumumab and Pomalidomide Versus Daratumumab in Combination With Pomalidomide and Dexamethasone in Participants With Multiple Myeloma That Returns After Treatment or is Resistant to Treatment — Running, not enrolling
• Bemarituzumab or Placebo Plus Chemotherapy in Gastric Cancers With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression — Completed
• Safety and Efficacy of Efavaleukin Alfa in Participants With Moderately to Severely Active Ulcerative Colitis — Stopped early